EN Official Journal of the European Union C 58/10

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2016

(2017/C 58/08)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2016, at their meeting on 28 October 2016:

Annex I List of new marketing authorisations Annex II List of renewed marketing authorisations Annex III List of extended marketing authorisations Annex IV List of withdrawn marketing authorisations Annex V List of suspended marketing authorisations

ANNEX I List of new marketing authorisations The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2016: EU-Number Product Country Date of authorisation EU/1/15/1053 Neofordex Liechtenstein 30.4.2016 EU/1/15/1053 Neofordex Iceland 31.3.2016 EU/1/15/1053 Neofordex Norway 1.4.2016 EU/1/15/1063 Pemetrexed Actavis Liechtenstein 29.2.2016 EU/1/15/1063 Pemetrexed Actavis Norway 25.1.2016 EU/1/15/1063 Pemetrexed Actavis Iceland 25.1.2016 EU/1/15/1064 Imlygic Liechtenstein 29.2.2016 EU/1/15/1064 Imlygic Norway 20.1.2016 EU/1/15/1064 Imlygic Iceland 14.1.2016 EU/1/15/1065 Eptifibatid Accord Liechtenstein 29.2.2016 EU/1/15/1065 Eptifibatide Accord Norway 18.1.2016 EU/1/15/1065 Eptifibatide Accord Iceland 14.1.2016 EU/1/15/1066 Ongentys Liechtenstein 30.6.2016 EU/1/15/1067 Lopinavir/Ritonavir Mylan Liechtenstein 29.2.2016 EU/1/15/1067 Lopinavir/Ritonavir Mylan Norway 21.1.2016 EU/1/15/1067 Lopinavir/Ritonavir Mylan Iceland 20.1.2016 EU/1/15/1068 Wakix Liechtenstein 30.4.2016 EU/1/15/1068 Wakix Norway 19.4.2016 EU/1/15/1068 Wakix Iceland 22.4.2016 EU/1/15/1069 Episalvan Liechtenstein 29.2.2016 EU/1/15/1069 Episalvan Norway 20.1.2016 EU/1/15/1069 Episalvan Iceland 19.1.2016 EU/1/15/1070 Oncaspar Liechtenstein 29.2.2016 EU/1/15/1070 Oncaspar Norway 25.1.2016 EU/1/15/1070 Oncaspar Iceland 25.1.2016 EU/1/15/1071 Pemetrexed Accord Liechtenstein 29.2.2016 EU/1/15/1071 Pemetrexed Accord Norway 25.1.2016 EU/1/15/1071 Pemetrexed Accord Iceland 25.1.2016 EU/1/15/1072 Spectrila Liechtenstein 29.2.2016 EU/1/15/1072 Spectrila Norway 19.1.2016 EU/1/15/1072 Spectrila Iceland 19.1.2016 EU/1/15/1073 Briviact Liechtenstein 29.2.2016 EU/1/15/1073 Briviact Norway 21.1.2016 EU/1/15/1073 Briviact Iceland 25.1.2016 EU/1/15/1074 Benepali Liechtenstein 29.2.2016 EU/1/15/1074 Benepali Norway 19.1.2016 EU/1/15/1074 Benepali Iceland 19.1.2016 EU/1/15/1075 Feraccru Liechtenstein 29.2.2016 EU/1/15/1075 Feraccru Norway 7.3.2016 EU/1/15/1075 Feraccru Iceland 18.3.2016 EU/1/15/1076 Kovaltry Liechtenstein 29.2.2016 EU/1/15/1076 Kovaltry Norway 10.3.2016 EU/1/15/1076 Kovaltry Iceland 16.3.2016 EU/1/15/1077 Iblias Liechtenstein 29.2.2016 EU/1/15/1077 Iblias Norway 10.3.2016 EU/1/15/1077 Iblias Iceland 16.3.2016 EU/1/15/1079 Vaxelis Liechtenstein 29.2.2016 EU/1/15/1079 Vaxelis Norway 29.2.2016 EU/1/15/1079 Vaxelis Iceland 1.3.2016 EU/1/15/1080 Zurampic Liechtenstein 29.2.2016 EU/1/15/1080 Zurampic Norway 3.3.2016 EU/1/15/1080 Zurampic Iceland 16.3.2016 EU/1/15/1081 Caspofungin Accord Liechtenstein 29.2.2016 EU/1/15/1081 Caspofungin Accord Norway 29.2.2016 EU/1/15/1081 Caspofungin Accord Iceland 25.2.2016 EU/1/15/1082 Galafold Liechtenstein 30.6.2016 EU/1/15/1082 Galafold Norway 14.6.2016 EU/1/15/1082 Galafold Iceland 14.6.2016 EU/1/15/1083 Uptravi Liechtenstein 30.6.2016 EU/1/15/1083 Uptravi Iceland 26.5.2016 EU/1/15/1083 Uptravi Norway 30.5.2016 EU/1/15/1084 Portrazza Liechtenstein 29.2.2016 EU/1/15/1084 Portrazza Norway 26.2.2016 EU/1/15/1084 Portrazza Iceland 15.3.2016 EU/1/15/1085 Taltz Liechtenstein 30.4.2016 EU/1/15/1085 Taltz Norway 9.5.2016 EU/1/15/1085 Taltz Iceland 20.5.2016 EU/1/16/1086 Tagrisso Liechtenstein 29.2.2016 EU/1/16/1086 Tagrisso Norway 19.2.2016 EU/1/16/1086 Tagrisso Iceland 11.2.2016 EU/1/16/1087 Coagadex Liechtenstein 30.4.2016 EU/1/16/1087 Coagadex Norway 1.4.2016 EU/1/16/1087 Coagadex Iceland 22.3.2016 EU/1/16/1088 Empliciti Liechtenstein 30.6.2016 EU/1/16/1088 Empliciti Norway 24.5.2016 EU/1/16/1088 Empliciti Iceland 19.5.2016 EU/1/16/1089 Pandemic influenza vaccine H5N1 MedImmune Liechtenstein 30.6.2016 EU/1/16/1089 Pandemic influenza vaccine H5N1 MedImmune Norway 30.5.2016 EU/1/16/1089 Pandemic influenza vaccine H5N1 MedImmune Iceland 30.5.2016 EU/1/16/1090 Rasagiline Mylan Liechtenstein 30.4.2016 EU/1/16/1090 Rasagiline Mylan Norway 19.4.2016 EU/1/16/1090 Rasagiline Mylan Iceland 22.4.2016 EU/1/16/1092 Amlodipin/Valsartan Mylan Liechtenstein 30.4.2016 EU/1/16/1092 Amlodipine/Valsartan Mylan Norway 11.4.2016 EU/1/16/1092 Amlodipine/Valsartan Mylan Iceland 31.3.2016 EU/1/16/1093 Zonisamide Mylan Liechtenstein 30.4.2016 EU/1/16/1093 Zonisamide Mylan Norway 19.4.2016 EU/1/16/1093 Zonisamide Mylan Iceland 22.4.2016 EU/1/16/1095 Idelvion Liechtenstein 30.6.2016 EU/1/16/1095 Idelvion Norway 30.5.2016 EU/1/16/1095 Idelvion Iceland 23.5.2016 EU/1/16/1096 Lonsurf Liechtenstein 30.4.2016 EU/1/16/1096 Lonsurf Norway 9.5.2016 EU/1/16/1096 Lonsurf Iceland 20.5.2016 EU/1/16/1097 Strimvelis Liechtenstein 30.6.2016 EU/1/16/1097 Strimvelis Norway 9.6.2016 EU/1/16/1097 Strimvelis Iceland 16.6.2016 EU/1/16/1098 Alprolix Liechtenstein 30.6.2016 EU/1/16/1098 Alprolix Norway 25.5.2016 EU/1/16/1098 Alprolix Iceland 20.5.2016 EU/1/16/1099 Descovy Liechtenstein 30.4.2016 EU/1/16/1099 Descovy Norway 27.4.2016 EU/1/16/1099 Descovy Iceland 18.5.2016 EU/1/16/1100 Palonosetron Hospira Liechtenstein 30.4.2016 EU/1/16/1100 Palonosetron Hospira Norway 19.4.2016 EU/1/16/1100 Palonosetron Hospira Iceland 27.4.2016 EU/1/16/1101 Darzalex Liechtenstein 30.6.2016 EU/1/16/1101 Darzalex Norway 30.5.2016 EU/1/16/1101 Darzalex Iceland 30.5.2016 EU/1/16/1103 Neparvis Liechtenstein 30.6.2016 EU/1/16/1103 Neparvis Norway 24.6.2016 EU/1/16/1104 Palonosetron Accord Liechtenstein 30.6.2016 EU/1/16/1104 Palonosteron Accord Norway 14.6.2016 EU/1/16/1104 Palonosetron Accord Iceland 14.6.2016 EU/1/16/1106 Flixabi Liechtenstein 30.6.2016 EU/1/16/1106 Flixabi Norway 17.6.2016 EU/1/16/1106 Flixabi Iceland 15.6.2016 EU/1/16/1109 Zavicefta Liechtenstein 30.6.2016 EU/1/16/1112 Odefsey Liechtenstein 30.6.2016 EU/1/16/1112 Odefsey Norway 24.6.2016 EU/2/15/192 Velactis Norway 4.1.2016 EU/2/15/193 Imrestor Norway 5.1.2016 EU/2/15/193 Imrestor Iceland 4.1.2016 EU/2/16/194 Evalon Liechtenstein 30.4.2016 EU/2/16/194 Evalon Norway 11.5.2016 EU/2/16/194 Evalon Iceland 13.5.2016 EU/2/16/195 Letifend Liechtenstein 30.4.2016 EU/2/16/195 Letifend Norway 27.4.2016 EU/2/16/195 Letifend Iceland 18.5.2016

ANNEX II List of renewed marketing authorisations The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2016: EU-Number Product Country Date of authorisation EU/1/05/323 ProQuad Iceland 4.1.2016 EU/1/05/323 ProQuad Norway 11.1.2016 EU/1/05/330 Rotarix Liechtenstein 29.2.2016 EU/1/05/330 Rotarix Iceland 20.1.2016 EU/1/05/330 Rotarix Norway 20.1.2016 EU/1/05/331 Neupro Liechtenstein 29.2.2016 EU/1/05/331 Neupro Iceland 28.1.2016 EU/1/05/331 Neupro Norway 4.2.2016 EU/1/06/334 Evoltra Liechtenstein 29.2.2016 EU/1/06/334 Evoltra Norway 19.1.2016 EU/1/06/334 Evoltra Iceland 20.1.2016 EU/1/06/336 Tygacil Liechtenstein 29.2.2016 EU/1/06/336 Tygacil Norway 18.3.2016 EU/1/06/336 Tygacil Iceland 18.3.2016 EU/1/06/341 Zostavax Liechtenstein 29.2.2016 EU/1/06/341 Zostavax Norway 29.2.2016 EU/1/06/341 Zostavax Iceland 18.2.2016 EU/1/06/346 Tysabri Norway 29.4.2016 EU/1/06/346 Tysabri Iceland 12.5.2016 EU/1/06/354 Competact Liechtenstein 30.4.2016 EU/1/06/354 Competact Norway 12.5.2016 EU/1/06/354 Competact Iceland 18.5.2016 EU/1/06/356 Exjade Liechtenstein 30.4.2016 EU/1/06/356 Exjade Norway 2.5.2016 EU/1/06/356 Exjade Iceland 12.5.2016 EU/1/09/543 Cayston Liechtenstein 30.6.2016 EU/1/09/543 Cayston Norway 14.6.2016 EU/1/09/543 Cayston Iceland 13.6.2016 EU/1/10/652 TOBI Podhaler Liechtenstein 29.2.2016 EU/1/10/652 TOBI Podhaler Norway 1.3.2016 EU/1/10/652 TOBI Podhaler Iceland 17.3.2016 EU/1/11/671 Xiapex Liechtenstein 29.2.2016 EU/1/11/671 Xiapex Norway 25.1.2016 EU/1/11/671 Xiapex Iceland 27.1.2016 EU/1/11/672 Xeplion Norway 11.1.2016 EU/1/11/672 Xeplion Iceland 4.1.2016 EU/1/11/674 Repso Liechtenstein 29.2.2016 EU/1/11/674 Repso Norway 25.1.2016 EU/1/11/674 Repso Iceland 20.1.2016 EU/1/11/679 Pravafenix Liechtenstein 29.2.2016 EU/1/11/679 Pravafenix Norway 2.2.2016 EU/1/11/679 Pravafenix Iceland 26.1.2016 EU/1/11/681 Trobalt Liechtenstein 29.2.2016 EU/1/11/681 Trobalt Norway 25.1.2016 EU/1/11/681 Trobalt Iceland 26.1.2016 EU/1/11/682 Methylthioninium chloride Proveblue Norway 29.2.2016 EU/1/11/682 Methylthioninium chloride Proveblue Iceland 16.2.2016 EU/1/11/682 Methylthioniniumchlorid Proveblue Liechtenstein 29.2.2016 EU/1/11/685 Ibandronic acid Sandoz Norway 11.5.2016 EU/1/11/685 Ibandronic acid Sandoz Iceland 27.4.2016 EU/1/11/687 Hizentra Liechtenstein 29.2.2016 EU/1/11/687 Hizentra Norway 29.2.2016 EU/1/11/687 Hizentra Iceland 17.3.2016 EU/1/11/688 Cinryze Liechtenstein 30.6.2016 EU/1/11/688 Cinryze Norway 22.6.2016 EU/1/11/688 Cinryze Iceland 13.6.2016 EU/1/11/690 Zoely Liechtenstein 30.4.2016 EU/1/11/690 Zoely Norway 29.4.2016 EU/1/11/690 Zoely Iceland 18.5.2016 EU/1/11/691 Eliquis Liechtenstein 29.2.2016 EU/1/11/691 Eliquis Norway 2.2.2016 EU/1/11/691 Eliquis Iceland 26.1.2016 EU/1/11/692 Yellox Liechtenstein 29.2.2016 EU/1/11/692 Yellox Norway 2.2.2016 EU/1/11/692 Yellox Iceland 19.1.2016 EU/1/11/693 Rivastigmin Actavis Norway 3.3.2016 EU/1/11/693 Rivastigmine Actavis Liechtenstein 29.2.2016 EU/1/11/693 Rivastigmine Actavis Iceland 15.3.2016 EU/1/11/694 Nulojix Liechtenstein 29.2.2016 EU/1/11/694 Nulojix Norway 26.2.2016 EU/1/11/694 Nulojix Iceland 17.3.2016 EU/1/11/695 Leganto Liechtenstein 29.2.2016 EU/1/11/695 Leganto Norway 1.2.2016 EU/1/11/695 Leganto Iceland 26.1.2016 EU/1/11/696 Bydureon Liechtenstein 29.2.2016 EU/1/11/696 Bydureon Norway 10.3.2016 EU/1/11/696 Bydureon Iceland 17.3.2016 EU/1/11/697 Temozolomide SUN Liechtenstein 30.4.2016 EU/1/11/697 Temozolomide SUN Norway 29.4.2016 EU/1/11/697 Temozolomide SUN Iceland 18.5.2016 EU/1/11/698 Yervoy Liechtenstein 30.4.2016 EU/1/11/698 Yervoy Norway 29.4.2016 EU/1/11/698 Yervoy Iceland 18.5.2016 EU/1/11/699 Fampyra Liechtenstein 30.6.2016 EU/1/11/699 Fampyra Iceland 15.6.2016 EU/1/11/700 Benlysta Liechtenstein 29.2.2016 EU/1/11/700 Benlysta Norway 26.2.2016 EU/1/11/700 Benlysta Iceland 18.3.2016 EU/1/11/702 Levetiracetam ratiopharm Liechtenstein 30.4.2016 EU/1/11/702 Levetiracetam ratiopharm Norway 18.5.2016 EU/1/11/702 Levetiracetam ratiopharm Iceland 19.5.2016 EU/1/11/703 Xgeva Liechtenstein 30.6.2016 EU/1/11/703 Xgeva Norway 18.5.2016 EU/1/11/703 Xgeva Iceland 13.5.2016 EU/1/11/704 Victrelis Liechtenstein 29.2.2016 EU/1/11/704 Victrelis Iceland 17.3.2016 EU/1/11/704 Victrelis Norway 3.3.2016 EU/1/11/705 Vibativ Liechtenstein 30.6.2016 EU/1/11/705 Vibativ Iceland 13.6.2016 EU/1/11/705 Vibativ Norway 9.6.2016 EU/1/11/706 Levodopa/Carbidopa/Entacapone Orion Liechtenstein 30.6.2016 EU/1/11/706 Levodopa/Carbidopa/Entacapone Orion Iceland 15.6.2016 EU/1/11/707 Trajenta Liechtenstein 30.4.2016 EU/1/11/707 Trajenta Norway 19.4.2016 EU/1/11/707 Trajenta Iceland 31.3.2016 EU/1/11/708 Entacapone Orion Liechtenstein 30.4.2016 EU/1/11/708 Entacapone Orion Norway 21.4.2016 EU/1/11/708 Entacapone Orion Iceland 26.4.2016 EU/1/11/709 Buccolam Liechtenstein 30.6.2016 EU/1/11/709 Buccolam Norway 24.6.2016 EU/1/11/709 Buccolam Iceland 13.6.2016 EU/1/11/714 Zytiga Liechtenstein 30.6.2016 EU/1/11/714 Zytiga Norway 14.6.2016 EU/1/11/714 Zytiga Iceland 13.6.2016 EU/1/11/718 Dexdor Liechtenstein 30.6.2016 EU/1/11/718 Dexdor Norway 20.6.2016 EU/1/11/718 Dexdor Iceland 13.6.2016 EU/1/11/719 Telmisartan Teva Pharma Liechtenstein 30.6.2016 EU/1/11/719 Telmisartan Teva Pharma Norway 23.6.2016 EU/1/11/749 Caprelsa Norway 14.1.2016 EU/1/11/749 Caprelsa Iceland 14.1.2016 EU/1/12/764 Pixuvri Liechtenstein 30.4.2016 EU/1/12/764 Pixuvri Norway 1.4.2016 EU/1/12/764 Pixuvri Iceland 31.3.2016 EU/1/13/818 Bosulif Norway 14.1.2016 EU/1/13/818 Bosulif Iceland 13.1.2016 EU/1/13/848 Erivedge Norway 16.6.2016 EU/1/13/848 Erivedge Iceland 15.6.2016 EU/1/13/875 Deltyba Norway 29.3.2016 EU/1/13/875 Deltyba Iceland 22.3.2016 EU/1/13/890 Cometriq Liechtenstein 29.2.2016 EU/1/13/890 Cometriq Norway 20.1.2016 EU/1/13/890 Cometriq Iceland 19.1.2016 EU/1/13/901 Sirturo Liechtenstein 29.2.2016 EU/1/13/901 Sirturo Norway 14.1.2016 EU/1/13/901 Sirturo Iceland 13.1.2016 EU/1/14/987 Holoclar Iceland 4.1.2016 EU/1/15/999 Zykadia Liechtenstein 30.4.2016 EU/1/15/999 Zykadia Norway 6.4.2016 EU/1/15/999 Zykadia Iceland 31.3.2016 EU/2/06/061 Nobilis Influenza H5N2 Norway 28.6.2016 EU/2/10/107 Veraflox Liechtenstein 29.2.2016 EU/2/10/107 Veraflox Norway 13.1.2016 EU/2/10/107 Veraflox Iceland 15.1.2016 EU/2/10/115 Comfortis Liechtenstein 29.2.2016 EU/2/10/115 Comfortis Norway 18.1.2016 EU/2/10/115 Comfortis Iceland 15.1.2016 EU/2/10/116 Melosus Liechtenstein 29.2.2016 EU/2/10/116 Melosus Norway 22.1.2016 EU/2/10/116 Melosus Iceland 22.1.2016 EU/2/10/118 Activyl Liechtenstein 29.2.2016 EU/2/10/118 Activyl Norway 29.1.2016 EU/2/10/118 Activyl Iceland 15.1.2016 EU/2/10/119 Cimalgex Liechtenstein 29.2.2016 EU/2/10/119 Cimalgex Norway 19.1.2016 EU/2/10/119 Cimalgex Iceland 15.1.2016 EU/2/11/120 Zulvac 1 + 8 Ovis Liechtenstein 29.2.2016 EU/2/11/120 Zulvac 1 + 8 Ovis Norway 19.1.2016 EU/2/11/120 Zulvac 1 + 8 Ovis Iceland 15.1.2016 EU/2/11/121 CaniLeish Liechtenstein 29.2.2016 EU/2/11/121 CaniLeish Norway 18.1.2016 EU/2/11/121 CaniLeish Iceland 15.1.2016 EU/2/11/122 Bluevac BTV8 Liechtenstein 30.4.2016 EU/2/11/122 Bluevac BTV8 Norway 29.3.2016 EU/2/11/122 Bluevac BTV8 Iceland 29.3.2016 EU/2/11/123 Procox Liechtenstein 29.2.2016 EU/2/11/123 Procox Norway 20.1.2016 EU/2/11/123 Procox Iceland 20.1.2016 EU/2/11/124 Zuprevo Liechtenstein 30.6.2016 EU/2/11/124 Zuprevo Norway 1.6.2016 EU/2/11/124 Zuprevo Iceland 26.5.2016 EU/2/11/125 Certifect Liechtenstein 30.4.2016 EU/2/11/125 Certifect Norway 4.5.2016 EU/2/11/125 Certifect Iceland 12.5.2016 EU/2/11/126 MS-H Impfstoff Liechtenstein 30.6.2016 EU/2/11/126 MS-H Vaccine Iceland 23.5.2016 EU/2/11/126 MS-H-Vaksine Norway 24.5.2016 EU/2/11/128 Emdocam Liechtenstein 30.6.2016 EU/2/11/128 Emdocam Norway 27.6.2016 EU/2/11/129 Proteq West Nile Liechtenstein 30.6.2016 EU/2/11/129 Proteq West Nile Norway 24.5.2016 EU/2/11/129 Proteq West Nile Iceland 23.5.2016 EU/2/11/130 Zulvac 1 Bovis Liechtenstein 30.4.2016 EU/2/11/130 Zulvac 1 Bovis Norway 2.5.2016 EU/2/11/130 Zulvac 1 Bovis Iceland 13.5.2016 EU/2/11/131 Zulvac 1 Ovis Liechtenstein 30.4.2016 EU/2/11/131 Zulvac 1 Ovis Norway 2.5.2016 EU/2/11/131 Zulvac 1 Ovis Iceland 13.5.2016

ANNEX III List of extended marketing authorisations The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2016: EU-Number Product Country Date of authorisation EU/1/03/262/011 Emend Norway 15.1.2016 EU/1/03/262/011 Emend Iceland 14.1.2016 EU/1/06/356/011-019 Exjade Norway 1.4.2016 EU/1/06/356/011-019 Exjade Iceland 31.3.2016 EU/1/10/612/010-013 Revolade Norway 14.4.2016 EU/1/10/612/010-013 Revolade Iceland 26.4.2016 EU/1/10/655/007-011 Brilique Norway 26.2.2016 EU/1/10/655/007-011 Brilique Iceland 18.3.2016 EU/1/13/851/004-006 Lojuxta Norway 1.3.2016 EU/1/13/851/004-006 Lojuxta Iceland 18.3.2016 EU/1/14/971/007-010 Trevicta Norway 7.6.2016 EU/1/14/971/007-010 Trevicta Iceland 15.6.2016 EU/1/98/067/004 Mabthera Iceland 15.6.2016 EU/1/98/067/004 Mabthera Norway 26.5.2016 EU/2/13/158/016-031 Bravecto Norway 7.6.2016 EU/2/13/158/016-031 Bravecto Iceland 25.5.2016

ANNEX IV List of withdrawn marketing authorisations The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2016: EU-Number Product Country Date of withdrawal EU/1/01/179 Osigraft Norway 18.1.2016 EU/1/01/179 Osigraft Iceland 4.1.2016 EU/1/05/314 Kepivance Liechtenstein 30.4.2016 EU/1/05/314 Kepivance Iceland 29.3.2016 EU/1/05/314 Kepivance Norway 22.3.2016 EU/1/13/831 Capecitabin SUN Liechtenstein 30.6.2016 EU/1/13/833 Nuedexta Liechtenstein 30.4.2016 EU/1/13/833 Nuedexta Norway 31.3.2016 EU/1/13/833 Nuedexta Iceland 21.3.2016 EU/1/14/942 Clopidogrel/Acetylsalicylic acid Teva Norway 15.6.2016 EU/2/12/138 RevitaCAM Liechtenstein 30.6.2016 EU/2/12/138 RevitaCAM Norway 15.6.2016 EU/2/12/138 RevitaCAM Iceland 13.6.2016